These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein. Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D; J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785 [TBL] [Abstract][Full Text] [Related]
3. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic. Shea YF; Ha J; Chu LW Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477 [TBL] [Abstract][Full Text] [Related]
4. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Hampel H; Buerger K; Zinkowski R; Teipel SJ; Goernitz A; Andreasen N; Sjoegren M; DeBernardis J; Kerkman D; Ishiguro K; Ohno H; Vanmechelen E; Vanderstichele H; McCulloch C; Moller HJ; Davies P; Blennow K Arch Gen Psychiatry; 2004 Jan; 61(1):95-102. PubMed ID: 14706948 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias. Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566 [TBL] [Abstract][Full Text] [Related]
6. Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias. Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Trenkwalder C; Otto M; Stiens G; Rüther E; Kornhuber J; Wiltfang J Mol Psychiatry; 2007 Jul; 12(7):671-80. PubMed ID: 17339876 [TBL] [Abstract][Full Text] [Related]
7. Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study. Perri R; Monaco M; Fadda L; Caltagirone C; Carlesimo GA J Alzheimers Dis; 2014; 39(3):669-77. PubMed ID: 24254701 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease? Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders. Spies PE; Melis RJ; Sjögren MJ; Rikkert MG; Verbeek MM J Alzheimers Dis; 2009; 16(2):363-9. PubMed ID: 19221426 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis. Struyfs H; Van Broeck B; Timmers M; Fransen E; Sleegers K; Van Broeckhoven C; De Deyn PP; Streffer JR; Mercken M; Engelborghs S J Alzheimers Dis; 2015; 45(3):813-22. PubMed ID: 25633670 [TBL] [Abstract][Full Text] [Related]
11. [Biomarkers in spinal fluid of patients with dementia]. Skogseth RE; Fladby T; Mulugeta E; Aarsland D Tidsskr Nor Laegeforen; 2011 Nov; 131(22):2235-8. PubMed ID: 22085948 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid NrCAM is not a Suitable Biomarker to Discriminate between Dementia Disorders--A Pilot Study. Müller M; Claassen JA; Kuiperij HB; Verbeek MM J Alzheimers Dis; 2015; 46(3):605-9. PubMed ID: 25812850 [TBL] [Abstract][Full Text] [Related]
13. Word list and story recall elicit different patterns of memory deficit in patients with Alzheimer's disease, frontotemporal dementia, subcortical ischemic vascular disease, and Lewy body dementia. Perri R; Fadda L; Caltagirone C; Carlesimo GA J Alzheimers Dis; 2013; 37(1):99-107. PubMed ID: 23792693 [TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias. de Souza LC; Lamari F; Belliard S; Jardel C; Houillier C; De Paz R; Dubois B; Sarazin M J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):240-6. PubMed ID: 20802215 [TBL] [Abstract][Full Text] [Related]
15. Application of the PredictAD decision support tool to a Danish cohort of patients with Alzheimer's disease and other dementias. Simonsen AH; Mattila J; Hejl AM; Garde E; van Gils M; Thomsen C; Lötjönen J; Soininen H; Waldemar G Dement Geriatr Cogn Disord; 2014; 37(3-4):207-13. PubMed ID: 24193095 [TBL] [Abstract][Full Text] [Related]
16. Overlap between frontotemporal dementia and Alzheimer's disease: cerebrospinal fluid pattern and neuroimaging study. Padovani A; Premi E; Pilotto A; Gazzina S; Cosseddu M; Archetti S; Cancelli V; Paghera B; Borroni B J Alzheimers Dis; 2013; 36(1):49-55. PubMed ID: 23568100 [TBL] [Abstract][Full Text] [Related]